Immunomedics Inc. (IMMU) Profile

Profile for Immunomedics Inc. (IMMU)


Business Description: Immunomedics, Inc. is a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.

Address:	300 American Road, Morris Plains, NJ, 07950
Telephone:	(973) 605-8200	Website:	www.immunomedics.com
Facsimile:	(973) 605-8282	Email:	info@immunomedics.com Contact


Details

CEO:	Ms. Cynthia L. Sullivan
Employees:	121	Market Cap:	277.93 m
Issue Type:	CS
Auditor:	Ernst & Young LLP
Last Audit:	Unqualified
Indices:	Biotechnology


Industry Classifications

Sector:	Healthcare	CIK:	0000722830
Industry:	Drugs
Sub-Industry:	Biotechnology
NAICS:	In-Vitro Diagnostic Substance Manufacturing (325413)
SIC:	Surgical And Medical Instruments And Apparatus (3841), In Vitro And In Vivo Diagnostic Substances (2835), Commercial Physical And Biological Research (8731)

Tags for Immunomedics Inc.

Research stocks or mutual funds related to Immunomedics Inc. by keywords or tags. Find companies that have a similar focus to IMMU. The keywords below have been associated to IMMU by either user submission or electronic means.

corporate governance quotient investor relations company corporate financial clinical development clinical cost corporate governance training Commercial Physical And Biological Research (8731) disney annual report biotech europe hong kong stock quote board of director clinical diagnostics financial information financial annual report europe pharmaceuticals annual report annual reports disney corporate governance financial report corporate governance issues clinical research medical device distributor business development europe investor relations data define corporate governance board of directors role good corporate governance nyse stock quote clinical trials industry online investor relations corporate governance disclosure board of directors governance board governance role of the board of directors Drugs annual report of company europe profile corporate annual report good governance pharma clinical trials antibody manufacturing 3m annual report financial stock report what is it governance corporate governance and compliance compliance duties of directors financial investor clinical trials europe pharmaceutical distributor

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.